CAR T start-up Link Cell names BMS, SystImmune vet Jie D’Elia CEO

Link Cell Therapies Inc. named former SystImmune veteran Jie D’Elia as CEO and Roche and Iovance alum Friedrich Graf Finckenstein as CMO. Brian Slingerland, who co-founded the Austin- and South San Francisco-based CAR T company in 2022 with Robbie Majzner and Crystal Mackall, is now Executive Chair. 

D’Elia was CEO of SystImmune Inc., a multi-specific antibody and antibody-drug conjugate company; before that, she spent 11 years at BMS, culminating in a role as SVP of Business Development, Oncology, Hematology, and Cell Therapy. Graf Finckenstein was most recently CMO of Iovance Biotherapeutics Inc., which develops tumor infiltrating lymphocytes...